Skip to main content

previous disabled Page of 2
and
  1. Article

    Open Access

    Influence of donor age and donor-recipient age difference on intimal hyperplasia in pediatric patients with young and adult donors vs. adult patients after heart transplantation

    Optimal selection and allocation of donor hearts is a relevant aspect in transplantation medicine. Donor age and cardiac allograft vasculopathy (CAV) affect post-transplant mortality. To what extent donor age ...

    Sarah Ulrich, Leonie Arnold, Sebastian Michel in Clinical Research in Cardiology (2024)

  2. Article

    Empfehlungen für die Dokumentation des Arzt-Vorbehalts für die stationäre Leistungserbringung im Rahmen des AOP-Vertrags 2023

    Christoph Stellbrink, Michael A. Weber, Lutz Frankenstein, Bernd Nowak in Die Kardiologie (2023)

  3. Article

    Open Access

    Quality of life of patients with coronary heart disease treated with the bioresorbable vascular scaffold (ABSORB™): 2-year results from the GABI-R-registry

    Numerous studies have reported clinical endpoints following coronary revascularization using bioresorbable vascular scaffolds (BVS), while information about the impact on health-related quality of life is spar...

    Kathrin Pahmeier, Silke Neusser, Christian Hamm in BMC Cardiovascular Disorders (2022)

  4. Article

    Open Access

    Permanent pacemaker dependency in patients with new left bundle branch block and new first degree atrioventricular block after transcatheter aortic valve implantation

    Conduction disorders with need for permanent pacemaker (PPM) implantation remain frequent complications after transcatheter aortic valve implantation (TAVI). Up to 22% of PPM after TAVI are implanted for new o...

    Bonnie Hartrampf, David Jochheim, Julius Steffen, Thomas Czermak in Scientific Reports (2021)

  5. No Access

    Article

    Kommentar zu den 2020er Leitlinien der Europäischen Gesellschaft für Kardiologie (ESC) zum Management des akuten Koronarsyndroms bei Patienten ohne persistierende ST-Strecken-Hebung

    Die im August 2020 publizierten Leitlinien der European Society of Cardiology (ESC) zum Management des akuten Koronarsyndroms ohne persistierende ST-Strecken-Hebungen (NSTE-ACS) ersetzen die zuletzt 2015 veröf...

    Univ.-Prof. Dr. Holger Thiele, Johann Bauersachs, Julinda Mehilli in Der Kardiologe (2021)

  6. No Access

    Article

    Antithrombotische Therapie nach strukturellen kardialen Interventionen

    In den letzten Jahren finden strukturelle kardiale Interventionen zunehmend Anwendung in der klinischen Routine. Trotz der raschen Einführung und Weiterentwicklung dieser Techniken, ist die Evidenz für die opt...

    Prof. Dr. Willibald Hochholzer, Thomas Nührenberg, Ulrike Flierl in Der Kardiologe (2021)

  7. No Access

    Article

    Comparison between treatment of “established” versus complex “off-label” coronary lesions with Absorb® bioresorbable scaffold implantation: results from the GABI-R® registry

    The purpose of this study was to compare the clinical outcomes of patients treated with bioresorbable scaffold (BRS) for off-label versus approved indications.

    Aydin Huseynov, Stefan Baumann, Holger Nef in Clinical Research in Cardiology (2020)

  8. No Access

    Book

  9. Article

    Open Access

    Six Versus Twelve Months Clopidogrel Therapy After Drug-Eluting Stenting in Patients With Acute Coronary Syndrome: An ISAR-SAFE Study Subgroup Analysis

    In patients presenting with acute coronary syndrome (ACS) the optimal duration of dual-antiplatelet therapy after drug-eluting stent (DES) implantation remains unclear. At 6 months after intervention, patients...

    Raphaela Lohaus, Jonathan Michel, Katharina Mayer, Anna Lena Lahmann in Scientific Reports (2016)

  10. No Access

    Article

    Three-year efficacy and safety of new- versus early-generation drug-eluting stents for unprotected left main coronary artery disease insights from the ISAR-LEFT MAIN and ISAR-LEFT MAIN 2 trials

    In percutaneous coronary intervention (PCI) patients new-generation drug-eluting stent (DES) has reduced adverse events in comparison to early-generation DES. The aim of the current study was to investigate th...

    Salvatore Cassese, Sebastian Kufner, Erion Xhepa in Clinical Research in Cardiology (2016)

  11. No Access

    Article

    Gender differences in therapeutic recommendation after diagnostic coronary angiography: insights from the Coronary Angiography and PCI Registry of the German Society of Cardiology

    There is information suggesting differences and underuse of invasive coronary diagnostic and therapeutic procedures in women compared to men.

    Tobias Heer, Matthias Hochadel, Karin Schmidt in Clinical Research in Cardiology (2015)

  12. No Access

    Article

    Randomized comparison of biolimus-eluting stents with biodegradable polymer versus everolimus-eluting stents with permanent polymer coatings assessed by optical coherence tomography

    We sought to compare the healing patterns of biolimus-eluting stents with biodegradable polymer (BP-BES, Nobori) versus everolimus-eluting stents with permanent polymer (PP-EES, **ence) using intravascular opt...

    Tomohisa Tada, Adnan Kastrati in The International Journal of Cardiovascula… (2014)

  13. No Access

    Article

    Gender Differences in Cardiovascular Therapy: Focus on Antithrombotic Therapy and Percutaneous Coronary Intervention

    The epidemiology of coronary artery disease (CAD) differs between women and men: female cardiac patients are older and have poorer risk profiles than their male counterparts. This results in a preferential exc...

    Juan Luis Gutiérrez-Chico, Julinda Mehilli in Drugs (2013)

  14. No Access

    Article

    Influence of abciximab on evolution of left ventricular function in patients with non-ST-segment elevation acute coronary syndromes undergoing PCI after clopidogrel pretreatment: lessons from the ISAR-REACT 2 trial

    Abciximab reduced the combined endpoint of death, myocardial infarction (MI) and target vessel revascularization in patients with non-ST-segment elevation acute coronary syndromes (NSTE-ACS) undergoing percuta...

    Stefanie Schulz, Julinda Mehilli, G** Ndrepepa in Clinical Research in Cardiology (2011)

  15. No Access

    Article

    Statin effect on thrombin inhibitor effectiveness during percutaneous coronary intervention: a post-hoc analysis from the ISAR-REACT 3 trial

    To determine whether statin therapy influences the efficacy of thrombin inhibitor bivalirudin or unfractionated heparin (UFH) during PCI.

    Ahmed A. Khattab, G** Ndrepepa, Stefanie Schulz in Clinical Research in Cardiology (2011)

  16. No Access

    Article

    One-year clinical outcomes with abciximab in acute myocardial infarction: results of the BRAVE-3 randomized trial

    In the Bavarian Reperfusion Alternatives Evaluation (BRAVE)-3 study upstream administration of abciximab additional to 600 mg clopidogrel loading did not reduce the infarct size in patients with acute ST-segme...

    Stefanie Schulz, K. Anette Birkmeier, G** Ndrepepa in Clinical Research in Cardiology (2010)

  17. No Access

    Article

    Characterization of patients with bleeding complications who are at increased risk of death after percutaneous coronary intervention

    Bleeding complications in patients undergoing percutaneous coronary interventions (PCIs) are associated with increased risk of subsequent mortality. We undertook this study to characterize the subset of patien...

    G** Ndrepepa, Dritan Keta, Stefanie Schulz, Julinda Mehilli in Heart and Vessels (2010)

  18. No Access

    Article

    Drug-eluting stents in acute myocardial infarction: updated meta-analysis of randomized trials

    Use of drug-eluting stents in patients with acute myocardial infarction (AMI) remains an “off label” indication due to concerns regarding their performance in this patient subset.

    Alban Dibra, Klaus Tiroch, Stefanie Schulz in Clinical Research in Cardiology (2010)

  19. No Access

    Article

    Prognostic value of minimal blood flow restoration in patients with acute myocardial infarction after reperfusion therapy

    The prognostic impact of low-flow reperfusion after percutaneous coronary intervention (PCI) in patients with ST-segment elevation acute myocardial infarction (STEMI) is unknown. The aim of the study was to in...

    G** Ndrepepa, Dritan Keta, Stefanie Schulz in Clinical Research in Cardiology (2010)

  20. No Access

    Article

    Platelets contribute to postnatal occlusion of the ductus arteriosus

    Premature infants can suffer from an anatomical defect in which the ductus arteriosus, a blood vessel that connects the pulmonary artery and the aorta during fetal development, fails to close at birth. Katrin ...

    Katrin Echtler, Konstantin Stark, Michael Lorenz, Sandra Kerstan in Nature Medicine (2010)

previous disabled Page of 2